Partner Headlines - ICPT

  1. Mid-Morning Market Update: Markets Open Lower; Carlyle Group ...

    Benzinga
  2. Morning Market Gainers

    Benzinga
  3. FDA Grants Priority Review for Intercept's Obeticholic Acid for ...

    Benzinga
  4. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga
  5. Sportsman's Warehouse, Bob Evans, Peabody Energy Lead Tuesday's ...

    Benzinga
  6. Benzinga's Top Initiations

    Benzinga
  7. Barclays Initiates Intercept Pharmaceuticals With Overweight

    Benzinga
  8. Intercept Pharmaceuticals Inc (ICPT) Moves Forward With OCA REGENERATE ...

    GuruFocus
  9. Intercept has a design for test

    IBD
  10. Intercept's NASH Trial Design Irks Investors

    IBD
  11. Will The Bulls In Options Continue To Be Disappointed This Week?

    Benzinga
  12. Analysts are Positive on Intercept Pharmaceuticals Inc Following ...

    GuruFocus
  13. Earnings Scheduled For March 2, 2015

    Benzinga
  14. Making Money With Charles Payne: 02/06/15

    FoxBusiness
  15. Wedbush Highlights 2015 Catalysts for Emerging BioPharmaceuticals ...

    GuruFocus
  16. Cowen And Company Analyst Explains Why Intercept Pharmaceuticals ...

    Benzinga
  17. Cowen Analyst Likes Intercept Pharmaceuticals, ACADIA Pharmaceuticals ...

    Benzinga
  18. Mid-Afternoon Market Update: Crude Oil Jumps 7.5%; Visa Shares ...

    Benzinga
  19. Intercept Pharmaceuticals Soars 20%, Possible Short Squeeze

    Benzinga
  20. Mid-Day Market Update: Amazon Jumps On Upbeat Earnings; Hawaiian ...

    Benzinga
  21. Intercept Pharmaceuticals (ICPT) Obeticholic Acid Momentum, Gigamon ...

    GuruFocus
  22. Benzinga's Volume Movers

    Benzinga
  23. Mid-Morning Market Update: Markets Drop; Mastercard Profit Tops ...

    Benzinga
  24. Morning Market Gainers

    Benzinga
  25. Friday Morning Movers: Amazon Pops, Deckers Outdoor Plummets ...

    Benzinga
  26. Stock Futures Sharpen Losses; Amazon, Visa, MasterCard Climb

    IBD
  27. Benzinga's Top #PreMarket Gainers

    Benzinga
  28. INTERCEPT PHARMACEUTICALS

    IBD
  29. Deutsche Bank: No Big Move In FY15 For Intercept Pharmaceuticals

    Benzinga
  30. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  31. Gilead Acquires Drug Program For Fatty Liver Disease

    IBD
  32. IPO Stock Watch: FibroGen Up With Liver-Disease Field

    IBD
  33. Making Money With Charles Payne: 12/22/14

    FoxBusiness
  34. Intercept Announces Publication Of Meta-Analysis From The Global ...

    Benzinga
  35. Here Are The Top 25 Analysts On Wall Street

    Benzinga
  36. Stock Movers: Why Medicals Issues Are Dipping Today

    IBD
  37. Mid-Afternoon Market Update: Lions Gate Surges On Earnings Beat; ...

    Benzinga
  38. Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, ...

    Benzinga
  39. Morning Market Losers

    Benzinga
  40. Benzinga's Top #PreMarket Losers

    Benzinga
  41. Meet The 5 Companies Loving Obamacare

    Benzinga
  42. Morning Market Losers

    Benzinga
  43. Benzinga's Top #PreMarket Losers

    Benzinga
  44. Benzinga's Top Initiations

    Benzinga
  45. Cowen Initiates Intercept At Outperform

    Benzinga
  46. Four biotech takeover targets?

    IBD
  47. 4 Biotechs That Might Be Bought Soon

    IBD
  48. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  49. Morning Market Losers

    Benzinga
  50. Benzinga's Top #PreMarket Losers

    Benzinga
  51. CNBC's Stock Pops & Drops From August 12

    Benzinga
  52. Markets Marginally Lower In Quiet Trading Session

    Benzinga
  53. U.S. Job Openings Climb; Leerink Swann Bullish On Intercept Pharmaceuticals

    Benzinga
  54. U.S. Stocks Fall; Dealertrack Shares Surge On Upbeat Results

    Benzinga
  55. Markets Mostly Flat; Flowers Foods Profit Misses Estimates

    Benzinga
  56. Stocks Stake Out Thin Gains; Intercept, Insys, Autohome Gain

    IBD
  57. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD
  58. Benzinga's Volume Movers

    Benzinga
  59. Morning Market Movers

    Benzinga
  60. Conatus Shares Move Higher On Industry Data

    Benzinga
  61. Stock Futures Hem And Haw; Intercept Pharmaceuticals Soars

    IBD
  62. Benzinga's Top #PreMarket Gainers

    Benzinga
  63. Intercept Pharma Soars On Positive Liver Drug Data

    IBD
  64. INTERCEPT PHARMACEUTICALS

    IBD
  65. Intercept Pharmaceutical's Shares Soar On Earnings

    Benzinga
  66. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus
  67. Intercept Pharmaceutical Shares Up Amid Deutsche Bank Initiation

    Benzinga
  68. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  69. Benzinga's Top Initiations

    Benzinga
  70. Analysts Comment On Intercept Amid Share Decline Following FLINT ...

    Benzinga
  71. Top Healthcare Movers For June 9, 2014

    Benzinga
  72. Market Wrap For April 14: Markets Surge on Positive Retail Data, ...

    Benzinga
  73. Weekly CFO Sells Highlight: Intercept Pharmaceuticals Inc., ...

    GuruFocus
  74. Intercept Issues Preclinical Data Showing OCA's Potential Role ...

    Benzinga
  75. US Stock Futures Nudge Higher Ahead Of Jobs Data

    Benzinga
  76. Market Wrap For March 17: Investors Focused On Economic Data ...

    Benzinga
  77. Intercept Pharmaceuticals Announces Q4 Earnings

    Benzinga
  78. Stocks Near Session Highs; Kandi Up 26% On Q4 Results

    IBD
  79. Top Trending Tickers On StockTwits For March 17

    Benzinga
  80. Benzinga's Top #PreMarket Losers

    Benzinga
  81. Morning Gainers for Friday, March 14, 2014

    Benzinga
  82. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  83. Shares of Intercept Pharma Rise as BofA Sees US, EU Regulators ...

    Benzinga
  84. Fatty Liver Disease Should Keep Stocks Moving In 2014

    IBD
  85. Precious Metals, Health Care Led Mutual Funds In Feb.

    IBD
  86. Which Sector Produced 8 Of The 10 Top Percentage Gainers In 2 ...

    Benzinga
  87. Mid-Morning Market Update: Markets Rise; Bank of America Profit ...

    Benzinga
  88. Benzinga's Top #PreMarket Gainers

    Benzinga
  89. Market Wrap For January 14: Markets Rebound On Earnings Season ...

    Benzinga
  90. Mid-Afternoon Market Update: Markets Continue Rally as Tesla ...

    Benzinga
  91. Stocks Up In Afternoon; Tesla Soars On Strong Sales

    IBD
  92. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  93. Morning Market Losers

    Benzinga
  94. Benzinga's Top #PreMarket Losers

    Benzinga
  95. Intercept Reports Additional Details About FLINT Clinical Trial ...

    Benzinga
  96. Intercept to Present at the JP Morgan Healthcare Conference on ...

    Benzinga
  97. Market Wrap For January 10: Job Growth Weak, But Unemployment ...

    Benzinga
  98. Mid-Afternoon Market Update: Plug Rises on Secondary Pricing ...

    Benzinga
  99. Mid-Day Market Update: Abercrombie & Fitch Surges On Strong Outlook; ...

    Benzinga
  100. Intercept Shares Skyrocket 500% This Week

    FoxBusiness
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!